Drugs / VITHA-A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03654677 | Sep 2017 → Oct 2018 | hepatitis A virus infection | Boryung Pharmaceutical Co., Ltd | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VITHA-A | “To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine (VITHA-A)” NCT03654677 ↗ |
| Known as | inactivated hepatitis A vaccine | “To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine (VITHA-A)” NCT03654677 ↗ |
| Modality | Vaccine | “inactivated hepatitis A vaccine” NCT03654677 ↗ |
| Route | Intramuscular | “injected intramuscularly into the deltoid muscle” NCT03654677 ↗ |